No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

Therapeutic monoclonal antibodies (mAbs ... In this review, introductory notes on the development and systematic nomenclature of therapeutic mAbs in general, set the stage for a detailed ...

Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...

Paris: Sanofi has announced that the National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a standard-of-care regimen, bortezomib, lenalidomide, ...

The National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a standard-of-care regimen, bortezomib, lenalidomide, and dexamethasone (VRd), for the treatment ...

The National Medical Products Administration (NMPA) in China has approved Sarclisa, in combination with a standard-of-care regimen, bortezomib, lenalidomide, and dexamethasone (VRd), for the treatment ...

China NMPA approves Sanofi’s Sarclisa for patients with newly diagnosed multiple myeloma ineligible for transplant: Paris Saturday, February 1, 2025, 12:00 Hrs [IST] The Nationa ...

Sarclisa (isatuximab) has been approved in China for use in combination with the VRd regimen to treat newly diagnosed multiple myeloma patients w ...

Brand naming deserves more careful thought and strategy. After all, your business name will likely stick around for a long time - Pick a good one! What's in a name? A lot, actually. The right brand ...

Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant Approval based on positive results from the IMROZ phase 3 study ...

Google has applied the same locale-based labeling conventions to other locations subject to naming disputes. Outside of Japan and South Korea, the body of water bordering both nations is listed as ...

We encourage the use of Standard International Units in all manuscripts. Chemical compounds and biomolecules should be referred to using systematic nomenclature, preferably using the recommendations ...